The presence of CSCs in high-grade DCIS is associated with disease recurrence and resistance to radiotherapy via the FAK/Wnt pathway, and the use of FAK inhibitors can reduce cellular self-renewal while enhancing the effects of radiation in breast cancer [163]. The gene discussed is PTK2; the disease is ductal breast carcinoma in situ.